It takes too long and costs too much to bring new drugs to market. So let's beef up efforts to screen existing drugs for new uses, argue Curtis R. Chong and David J. Sullivan Jr.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. J. Health Econ. 22, 151–185 (2003).
Cohen, F. J. Nature Rev. Drug Discov. 4, 78–84 (2005).
Ashburn, T. T. & Thor, K. B. Nature Rev. Drug Discov. 3, 673–683 (2004).
Rothstein, J. D. et al. Nature 433, 73–77 (2005).
Moran, M. PLoS Med. 2, e302 (2005).
Sundar, S. et al. N. Engl. J. Med. 347, 1739–1746 (2002).
Chong, C. R. et al. Nature Chem. Biol. 2, 415–416 (2006).
Lipinski, C. A. et al. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Sussman, G. L. et al. J. Allergy Clin. Immunol. 104, 100–106 (1999).
Weber, W. W. Mol. Diagn. 4, 299–307 (1999).
Voigt, J. H. et al. J. Chem. Inf. Comput. Sci. 41, 702–712 (2001).
Wishart, D. S. et al. Nucleic Acids Res. 34, D668–D672 (2006).
Acknowledgements
We thank Walter Pudelko for invaluable help with Supplementary Table 2.
Supplementary information
Supplementary Table 1 (download DOC )
(DOC 100 kb)
Supplementary Table 2 (download XLS )
(XLS 818 kb)
Rights and permissions
About this article
Cite this article
Chong, C., Sullivan, D. New uses for old drugs. Nature 448, 645–646 (2007). https://doi.org/10.1038/448645a
Published:
Issue date:
DOI: https://doi.org/10.1038/448645a
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
